Education
About Us
Working with TipRanks
Follow Us
Harvard Apparatus Regenerative Technology (HRGN)
OTHER OTC:HRGN
Total Valuation
Harvard Apparatus Regenerative Technology has a market cap or net worth of $31.12M. The enterprise value is $29.29M.
Market Cap$31.12M
Enterprise Value$29.29M
Share Statistics
Harvard Apparatus Regenerative Technology has 17,580,744 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,580,744
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Harvard Apparatus Regenerative Technology’s return on equity (ROE) is -2.40 and return on invested capital (ROIC) is -231.97%.
Return on Equity (ROE)-2.40
Return on Assets (ROA)-1.74
Return on Invested Capital (ROIC)-231.97%
Return on Capital Employed (ROCE)-2.38
Revenue Per Employee0.00
Profits Per Employee-966.50K
Employee Count8
Asset Turnover0.00
Inventory Turnover3.38
Valuation Ratios
The current PE Ratio of Harvard Apparatus Regenerative Technology is ―. Harvard Apparatus Regenerative Technology’s PEG ratio is 0.25.
PE Ratio―
PS Ratio0.00
PB Ratio13.68
Price to Fair Value13.68
Price to FCF-9.08
Price to Operating Cash Flow122.59
PEG Ratio0.25
Income Statement
In the last 12 months, Harvard Apparatus Regenerative Technology had revenue of 0.00 and earned -7.73M in profits. Earnings per share was -0.52.
Revenue0.00
Gross Profit-270.00K
Operating Income-8.16M
Pretax Income-7.73M
Net Income-7.73M
EBITDA-8.16M
Earnings Per Share (EPS)-0.52
Cash Flow
In the last 12 months, operating cash flow was 264.00K and capital expenditures 11.00K, giving a free cash flow of 275.00K billion.
Operating Cash Flow264.00K
Free Cash Flow275.00K
Free Cash Flow per Share0.02
Dividends & Yields
Harvard Apparatus Regenerative Technology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.15
52-Week Price Change-38.81%
50-Day Moving Average1.81
200-Day Moving Average1.75
Relative Strength Index (RSI)49.77
Average Volume (3m)1.13K
Important Dates
Harvard Apparatus Regenerative Technology upcoming earnings date is May 18, 2026, Before Open (Confirmed).
Last Earnings DateAug 19, 2025
Next Earnings DateMay 18, 2026
Ex-Dividend Date―
Financial Position
Harvard Apparatus Regenerative Technology as a current ratio of 3.17, with Debt / Equity ratio of 14.41%
Current Ratio3.17
Quick Ratio3.09
Debt to Market Cap<0.01
Net Debt to EBITDA0.27
Interest Coverage Ratio-214.63
Taxes
In the past 12 months, Harvard Apparatus Regenerative Technology has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Harvard Apparatus Regenerative Technology EV to EBITDA ratio is -5.13, with an EV/FCF ratio of -8.63.
EV to Sales0.00
EV to EBITDA-5.13
EV to Free Cash Flow-8.63
EV to Operating Cash Flow-8.63
Balance Sheet
Harvard Apparatus Regenerative Technology has $1.32M in cash and marketable securities with $224.00K in debt, giving a net cash position of $1.09M billion.
Cash & Marketable Securities$1.32M
Total Debt$224.00K
Net Cash$1.09M
Net Cash Per Share$0.06
Tangible Book Value Per Share$0.22
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Harvard Apparatus Regenerative Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast216.17%
EPS Growth Forecast29.97%